Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Increases By 300.0%

Cocrystal Pharma, Inc. (NASDAQ:COCP) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 8,000 shares, a growth of 300.0% from the October 31st total of 2,000 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average daily volume of 18,100 shares, the short-interest ratio is currently 0.4 days.

Cocrystal Pharma Stock Down 3.8 %

Shares of NASDAQ COCP traded down $0.08 during trading on Friday, hitting $2.02. 4,055 shares of the company traded hands, compared to its average volume of 21,017. The firm has a market capitalization of $20.54 million, a P/E ratio of -1.14 and a beta of 1.45. The company has a 50-day moving average price of $1.89 and a 200-day moving average price of $2.03. Cocrystal Pharma has a 1 year low of $1.33 and a 1 year high of $3.10.

Analyst Ratings Changes

Separately, HC Wainwright reduced their target price on Cocrystal Pharma from $10.00 to $7.00 and set a “buy” rating on the stock in a research note on Thursday, August 22nd.

About Cocrystal Pharma

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.